Conmed buys Bristol-Myers' Linvatec for $370 million
This article was originally published in Clinica
Conmed is to buy the arthroscopy and surgical instruments of Bristol-Myers Squibb's Zimmer division for $370 million in cash. Conmed will acquire the Linvatec business, assets relating to Linvatec's international business and Hall Surgical. In addition, Bristol-Myers will receive a 10-year warrant to purchase one million Conmed shares at 130% of its 15-day average price.